TD Asset Management
KMTS

TD Asset Management’s Kestra Medical Technologies KMTS Stock Holding History

TD Asset Management’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.18M Sell
109,378
-23,482
-18% -$553K ﹤0.01% 945
2025
Q4 		$3.52M Buy
132,860
+40,554
+44% +$1.04M ﹤0.01% 861
2025
Q3 		$2.19M Buy
92,306
+13,588
+17% +$243K ﹤0.01% 943
2025
Q2 		$1.31M Sell
78,718
-13,830
-15% -$302K ﹤0.01% 1026
2025
Q1 		$2.31M Buy
+92,548
New +$2.13M ﹤0.01% 927

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

TD Asset Management's KMTS Position: Q1 2026 in Review

TD Asset Management reduced its Kestra Medical Technologies (KMTS) stake by 18% in Q1 2026, selling an estimated $553K and leaving 109,378 shares worth $2.18M. The position accounts for ﹤0.01% of the portfolio, ranked #945.

TD Asset Management first reported a position in KMTS in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.52M in Q4 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • TD Asset Management held 109,378 shares of Kestra Medical Technologies worth $2.18M as of Q1 2026.
  • TD Asset Management sold 23,482 Kestra Medical Technologies shares in Q1 2026, an estimated $553K.
  • Kestra Medical Technologies made up ﹤0.01% of TD Asset Management's portfolio in Q1 2026, its #945 holding.
  • TD Asset Management first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 5 quarters since.
  • TD Asset Management's Kestra Medical Technologies position peaked at $3.52M in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.